World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
75
Citations
19832
World Ranking
1195
National Ranking
619

Julia A. Bridge publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Julia A. Bridge sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 260 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Julia A. Bridge D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Julia A. Bridge sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 75 D-Index — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Julia A. Bridge is affiliated with the University of Nebraska Medical Center in the United States. Their research primarily focuses on the field of Medicine, with significant contributions in various subfields including Pulmonary and Respiratory Medicine, Rheumatology, Surgery, Oncology, and Molecular Biology.

The scientific work covers several main topics in biomedical research, notably:

  • Sarcoma Diagnosis and Treatment
  • Soft tissue tumor case studies
  • Histiocytic Disorders and Treatments
  • Cancer and Skin Lesions
  • Urologic and reproductive health conditions
  • Cardiac tumors and thrombi
  • Tumors and Oncological Cases

Julia A. Bridge has contributed to multiple recent papers, including:

  • EWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinoma (2021, Modern Pathology)
  • Validation of an mRNA-based Urine Test for the Detection of Bladder Cancer in Patients with Haematuria (2020, European Urology Oncology)
  • Clinicopathologic and Genomic Characterization of Inflammatory Myofibroblastic Tumors of the Head and Neck (2021, The American Journal of Surgical Pathology)
  • Myositis ossificans-like soft tissue aneurysmal bone cyst: a clinical, radiological, and pathological study of seven cases with COL1A1-USP6 fusion and a novel ANGPTL2-USP6 fusion (2020, Modern Pathology)
  • Inflammatory and Nested Testicular Sex Cord Tumor (2023, The American Journal of Surgical Pathology)

The frequent coauthors collaborating with Julia A. Bridge include:

  • Jiancong Liang
  • Konstantinos Linos
  • Frank Mezzacappa
  • Andrew Gard
  • Fatmagül Çabuk

Publications often appear in several key research venues where Julia A. Bridge is a recurring contributor:

  • Graduate Medical Education Research Journal
  • Journal of Cutaneous Pathology
  • Modern Pathology
  • Cancer Genetics
  • Genes Chromosomes and Cancer

Best Publications

  • A prospective, multi-institutional, pathologist-based assessment of 4 immunohistochemistry assays for PD-L1 expression in non–small cell lung cancer

    David L. Rimm;Gang Han;Janis M. Taube;Eunhee S. Yi

  • The der(17)t(x;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25

    Marc Ladanyi;Man Yee Lui;Cristina R Antonescu;Amber Krause-Boehm

  • Fusion of the ALK Gene to the Clathrin Heavy Chain Gene, CLTC, in Inflammatory Myofibroblastic Tumor

    Julia A. Bridge;Masahiko Kanamori;Zhigui Ma;Diane Pickering

  • Renal carcinomas with the t(6;11)(p21;q12): Clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR

    Pedram Argani;Marick Laé;Brian Hutchinson;Victor E. Reuter

  • USP6 (Tre2) Fusion Oncogenes in Aneurysmal Bone Cyst

    Andre M. Oliveira;Andre M. Oliveira;Bae Li Hsi;Stanislawa Weremowicz;Andrew E. Rosenberg

  • Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data

    Lu Wang;Toru Motoi;Raya Khanin;Adam Olshen

  • Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor.

    Zhigui Ma;D. Ashley Hill;Margaret H. Collins;Stephan W. Morris

  • Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum.

    Larisa V Debelenko;Susana C Raimondi;Najat Daw;Bangalore R Shivakumar

  • Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes

    Andre M. Oliveira;Andre M. Oliveira;Antonio R. Perez-Atayde;Paola Dal Cin;Mark C. Gebhardt

  • Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: clear cell sarcoma (malignant melanoma of soft parts).

    Unknown

  • The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas.

    Dong Fang;Haiyun Gan;Jeong Heon Lee;Jing Han

  • Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution

    Roland P. Kuiper;Marga Schepens;José Thijssen;Martien van Asseldonk

  • Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature

    Unknown

  • Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions.

    Frederic G. Barr;Stephen J. Qualman;Michele H. Macris;Natalya Melnyk

  • ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35)

    Gisele W.B. Colleoni;Julia A. Bridge;Bernardo Garicochea;Jian Liu

  • Translocation t(1;3)(p36.3;q25) is a nonrandom aberration in epithelioid hemangioendothelioma

    Unknown

  • Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family.

    Janos Sumegi;Renae Streblow;Robert W. Frayer;Paola Dal Cin

  • Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas.

    Jane Bayani;Maria Zielenska;Ajay Pandita;Khaldoun Al-Romaih

  • Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: an intergroup rhabdomyosarcoma study.

    Julia A. Bridge;Jian Liu;Vines Weibolt;Vines Weibolt;K. Scott Baker

  • Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes

    Julia A. Bridge;Jian Liu;Stephen J. Qualman;Stephen J. Qualman;Ron Suijkerbuijk;Ron Suijkerbuijk

Frequent Co-Authors

Marc Ladanyi
Marc Ladanyi Memorial Sloan Kettering Cancer Center
David M. Parham
David M. Parham Children's Hospital of Los Angeles
Warren G. Sanger
Warren G. Sanger University of Nebraska Medical Center
Cristina R. Antonescu
Cristina R. Antonescu Memorial Sloan Kettering Cancer Center
Paola Dal Cin
Paola Dal Cin Harvard Medical School
Jonathan A. Fletcher
Jonathan A. Fletcher Brigham and Women's Hospital
Avery A. Sandberg
Avery A. Sandberg Roswell Park Cancer Institute
Fredrik Mertens
Fredrik Mertens Lund University
Pedram Argani
Pedram Argani Johns Hopkins University
Alexander J. Lazar
Alexander J. Lazar The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Expanding your knowledge in Molecular Biology can open doors to various online degree options and flexible career pathways in the USA. Many students explore programs offered by a non profit online university, ensuring quality education and recognized accreditation. These institutions often provide robust support services and flexible online formats.

For veterans or active military personnel, there are also dedicated military friendly online colleges that understand the unique needs of service members and offer resources tailored to support their academic journeys.

Related fields, such as healthcare, social sciences, and psychology, are accessible through online programs as well. You might consider an online masters of social work for a clinical or community-oriented career, or explore accelerated masters psychology programs for fast-tracked entry into behavioral health roles.

With the convenience of online education, pursuing these degrees can enhance your expertise, broaden your career prospects, and allow you to make an impact in science, healthcare, and allied fields.

Best Scientists Citing Julia A. Bridge

Trending Scientists

Recently Published Articles